Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02958553 · ClinicalTrials.gov registry record · NA
EmPOWERing Active Seniors With Energy
A NA study, sponsored by Otto Bock Healthcare Products.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT02958553: Completed NA study, sponsored by Otto Bock Healthcare Products.
NCT02958553 is a NA study that has completed, run by Otto Bock Healthcare Products. The registered enrollment target is 8 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02958553, a NA study, has completed, sponsored by Otto Bock Healthcare Products.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
A pilot study comparing the emPOWER Ankle System to standard carbon fiber prosthetic feet, in active seniors.
Primary Outcome
The proportion of patients with a clinically meaningful change (improvement, no change, worsening) in the walking distance measured by the Six Minute Walk Test (6MWT). 6minWT improvement was defined as a minimum increase of 45 meters.
Interventions
- DEVICE emPOWER Ankle
- DEVICE Subject's own passive prosthesis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 2017-02-10 |
| Est. Completion | 2018-07-31 |
| Phase | NA |
What the finished NCT02958553 record still lists
NCT02958553 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 8 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which emPOWER Ankle is the first listed.
NCT02958553 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02958553 about?
NCT02958553 is a clinical study titled "EmPOWERing Active Seniors With Energy". A pilot study comparing the emPOWER Ankle System to standard carbon fiber prosthetic feet, in active seniors.
What is the current status of trial NCT02958553?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 2017-02-10. Estimated completion is 2018-07-31.
What interventions are being tested in trial NCT02958553?
The interventions under investigation include: emPOWER Ankle (DEVICE), Subject's own passive prosthesis (DEVICE).
Who is sponsoring clinical trial NCT02958553?
This trial is sponsored by Otto Bock Healthcare Products, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02958553's enrollment target sits among peer trials
8 1976th of 2000 higher than 19 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI